Tag: Janus Henderson Investors
Parse Biosciences secures $50m in Series C for single cell sequencing
Parse Biosciences has announced a significant milestone in their funding journey, securing a total of $50 million through a Series C equity raise and a ... Read More
Pyxis Oncology raises $152m in Series B round for cancer therapies
Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company ... Read More
Olema Oncology raises $54m for breast cancer drug candidate OP-1250
Olema Oncology, a California-based biopharma company focused on developing targeted therapies for women's cancers, has raised $54 million in a Series B financing round, which ... Read More